Mark Herpin Sells Shares of HBCP

Mark Herpin, the Senior Executive Vice President and Chief Operations Officer at HBCP, sold 110 shares of the company on June 12, 2026. The shares were sold at an average price of $68.08, resulting in a total transaction value of $7,488.80. This sale was not part of a pre-arranged trading plan.

Insider Buying and Selling at HBCP

In addition to Mark Herpin's recent sale, several other insiders have been active. Daniel Guidry sold 1,000 shares on May 21, 2026, at $65.01 each. Natalie Lemoine, the SEVP and Chief Administrative Officer, purchased 500 shares at $28.00 on May 15, 2026, and sold another 500 shares on the same day. John Zollinger IV, the SEVP and Chief Banking Officer, sold 867 shares at $62.77 on May 13, 2026. On the same day, David Kirkley, SEVP and Chief Financial Officer, sold 655 shares at $62.80.

Other Institutional Activity in HBCP

Several institutional investors have adjusted their positions in HBCP. Dimensional Fund Advisors LP grew its holdings by 7,792 shares, ending with 429,581 shares worth about $26,024,060. BlackRock, Inc. reduced its stake by 6,737 shares, leaving it with 411,940 shares valued at $24,955,326. Vanguard Capital Management LLC established a new position with 295,778 shares worth approximately $17,918,231. American Century Companies Inc increased its position by 25,614 shares, totaling 186,588 shares valued at $11,303,501. Geode Capital Management, LLC added 5,364 shares, resulting in a total of 164,365 shares worth $9,959,268.

Analysts Set New Price Targets

On April 22, 2026, Piper Sandler downgraded HBCP to a hold rating and set a price target of $69. Previously, on July 23, 2025, Raymond James maintained a buy rating with a $62 price target. Piper Sandler has historically maintained a buy rating, with targets ranging from $60 to $65 in the past.

Bottom Line

Mark Herpin's recent sale of HBCP shares is part of ongoing insider activity within the company. Investors closely watch these transactions as they can offer insights into management's view of the company's stock value. Institutional investors have also been adjusting their positions, with some increasing and others reducing their stakes. Piper Sandler's recent downgrade to hold reflects a cautious outlook on the stock, with a price target of $69.